Eli Lilly shares phase 3 data on triple agonist weight loss drug retatrutide

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Leerink reiterates Eli Lilly stock rating on gene therapy progress Hisse Senetleri 0 6
A Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Hisse Senetleri 0 18
A Micron, Eli Lilly among market cap stock movers on Wednesday Hisse Senetleri 0 10
A BMO reiterates Eli Lilly stock Outperform on Centessa acquisition Hisse Senetleri 0 33
A Guggenheim lowers Eli Lilly stock price target to $1,163 on Q1 estimates Hisse Senetleri 0 20
A Jefferies reiterates Buy on Eli Lilly stock, $1,300 target Hisse Senetleri 0 13
A Beijing courts Eli Lilly as weight-loss drug race drives $3bn China commitment Hisse Senetleri 0 36
A Eli Lilly shares rise as Novo Nordisk obesity drug misses trial goal Hisse Senetleri 0 21

Benzer konular

Üst